Through a series of preliminary pan-cancer analyses, we discovered that USP32 is significantly overexpressed in several cancer types such as BC, cholangiocarcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, HCC and GC (Fig. 1A). Here, USP32 is linked to hepatocellular carcinoma.